Research shows GHK-Cu promotes blood vessel formation, enhances cardiac tissue repair, and provides protection against ischemia-reperfusion injury through enhanced antioxidant responses and reduced oxidative damage
And so that to me is one more proof, one more proof that we need a product that your body can actually accept it, incorporate into their own DNA and use it when it needs to
If one or more is not, I think carefully about whether to delay further or to proceed with adjusted perioperative risk management (for example, extended DVT prophylaxis)
In clinical studies, it has been administered in doses between 0.5mcg/kg and roughly 16,000mcg/kg for up to 2 weeks [42, 43]
The goal is to test what changes the plan
insert the needle at 4590 into subcutaneous tissue [12] [13]